Accelerate your preclinical discoveries

The Transactional Research-Based pre-cinical CRO.

Years of experience

Humana Team

Preclinical studies performed

0 +

HUMANA Biosciences overview

Humana Biosciences is a tailored preclinical CRO focused to improve preclinical research efficacy.

We have a large expertise in Gastroenterology, Urology and Respiratory Pathologies. We also have additional expertise in Dermatology and Nephrology.

We regularly collaborate with Nutraceutical Companies as well as Companies specialized in Medicinal Plant Extracts.

Every study we conduct is a custom designed study tailored specifically for the client. We offer our customers the best predictive experimental models for chronic functional pathologies.

Our mission is to reduce the number of inefficacious candidates moving through to the later stages of clinical investigation by developing innovative experimental models (in vitro and in vivo). Partnering with Humana Biosciences also gives you on-demand access to ethically obtained human tissues.

OUR ULTIMATE AMBITION IS TO MAKE YOUR PRE-CLINICAL DRUG DEVELOPMENT MORE PREDICTIVE AND FASTER.

They trusted us

The Humana Experience

Services

Our services rely on the Translational Pharmacology Approach to enhance the predictivity of drug efficacy and safety.

We offer a wide range of models, including human tissues, ALI cultures, isolated tissues, and in vivo models in rodents.

Research Papers

Humana Biosciences was founded by Dr. Stefano Palea, a pharmacologist with over 35 years of experience in preclinical research, particularly in Urology.

Alongside a highly published Scientific Advisory Board, our expertise spans receptor pharmacology, neuro-urology, cilia analysis, botulinum toxin assays, and innovative drug delivery systems.

Research Project

Our internal research focuses on four key areas:

botulinum toxin potency testing using in vitro, ex vivo and in vivo assays;

3D cultures of human bronchial cells from healthy and diseased donors;

in vivo models of asthma and COPD in rodents;

and comparative pharmacology on pig and human smooth muscle tissues.

About us

Our team combines scientific expertise and long-term commitment, with over 200 years of collective experience in drug development and more than 750 publications in peer-reviewed journals.

This stability ensures robust, high-quality preclinical research.